MGTX News & Events

President Trump has approved a plan to fire Food and Drug Administration Commissioner Marty Makary, Kristin Brown and Ed O'Keefe of CBS News reports, citing two sources. The timing of his potential termination remains unknown, CBS adds. Similar reports of y Makary's firing emerged on Friday. Biotech stocks that could be impacted by the news include Moderna (MRNA), Sarepta (SRPT), Xencor (XNCR), PTC Therapeutics (PTCT), Biohaven (BHVN), Edgewise Therapeutics (EWTX), Design Therapeutics (DSGN), Ultragenyx (RARE), Dyne Therapeutics (DYN), Wave Life Sciences (WVE), MeiraGTx (MGTX), uniQure (QURE), Regenxbio (RGNX), Novavax (NVAX) and Lexeo Therapeutics (LXEO).

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly.WAR WITH IRAN:Iran's state news agency IRNA reported Sunday that the country sent its response to the latest proposed U.S. draft agreement for ending the war,The Wall Street Journal. The current phase of negotiations is focused exclusively on the cessation of hostilities in the region, said IRNA, which gave no further details of the Iranian response.Meanwhile, President Donald Trump stated in a Truth Social, "I have just read the response from Iran's so-called 'Representatives.' I don't like it - TOTALLY UNACCEPTABLE! Thank you for your attention to this matter."AI SECURITY ORDER:The White House is planning to order U.S. agencies to partner with AI firms to protect networks from AI-enabled cyber attacks, though the order would stop short of mandating government approval for cutting-edge models, Bloomberg's Maggie Eastland and Courtney Subramanian, citing people familiar with the mater. A draft directive from President Trump would overhaul existing cybersecurity information-sharing programs to include AI companies and address threats posed by the emerging tech, the authors note. Companies in AI software include Alphabet, Meta, OpenAI, and Anthropic.FDA COMMISSIONER:President Trump has signed off on a plan to fire Food and Drug Administration Commissioner Marty Makary, following a tumultuous period for the regulator that included clashes over vaping, abortion and drug policy, The Wall Street Journal's Liz Essley Whyte, citing people familiar with the matter. Makary is seen by other top administration leaders as struggling to manage his agency, sparring frequently with health department officials and at times the White House, the author notes. Biotech stocks that could be impacted by the news include Moderna, Sarepta, Xencor, PTC Therapeutics, Biohaven, Edgewise Therapeutics, Design Therapeutics, Ultragenyx, Avidity Biosciences, Dyne Therapeutics, Wave Life Sciences, MeiraGTx, uniQure, Regenxbio, Novavaxand Lexeo Therapeutics.

The Dow Jones closed slightly in positive territory, while the S&P 500 and Nasdaq were sharply higher after the April jobs report beat forecasts. Chip stocks rebounded after yesterday's pause, helping lift the Nasdaq back toward record territory. Oil briefly pushed back above $100 after renewed U.S.-Iran clashes in the Strait of Hormuz, but equities have largely treated each flare-up as temporary noise.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Nvidiawillin Irenand announced a partnership between the two companiesExpediareported, affirmed its FY26 revenue guidance, and announced a new $5B stock buyback authorizationAkamaireportedand provided its outlook for Q2 and FY26Blockprovided areport for Q1President Trump has signed off on a plan to fire Food and Drug Administration Commissioner Marty Makary,2. WALL STREET CALLS:BofAHubSpotto Underperform, while Citi, William Blair and Cantor Fitzgerald also downgraded HubSpot to Neutral-equivalent ratings after the company's Q1 results and commentaryDaiwaQualcommto OutperformWells FargoNiketo Equal WeightMorgan Stanley, TD Cowen and BofAPlanet Fitnessto Neutral-equivalent ratingsCraig-HallumAkamaito Buy3. AROUND THE WEB:PG&Ereleased an inquiry saying it was aware of damage at the Mission substation responsible for a December blackout in San Francisco but left the damaged equipment in place, SF Standard reportsAnthropic reached a cloud computing deal with Akamai, Bloomberg saysMeanwhile, Anthropic is weighing a deal for a nearly $1T valuation, FT reportsMeta'sAI push is causing anger and anxiety among the company's employees, NY Times reportsThe U.S. suspects Nvidiachips were smuggled tot Alibabavia Thailand, Bloomberg reports4. MOVERS:Monster Beverageadvanced after reportingArlo Technologiesrose afterand reiterating its FY26 outlookRocket Lab USAgained after providing anCloudflarefell after providing areport but also announcing 1,100 layoffsCoreWeavedeclined after reporting5. EARNINGS/GUIDANCE:Toyotareported a year-over-yearYelpand reiterated its FY26 revenue outlookGrouponreportedCoinbasereported a sharp drop inWendy'sreportedINDEXES:The Dow rose 12.19, or 0.025%, to 49,609.16, the Nasdaq gained 440.88, or 1.71%, to 26,247.08, and the S&P 500 advanced 61.82, or 0.84%, to 7,398.93.

President Trump has signed off on a plan to fire Food and Drug Administration Commissioner Marty Makary, following a tumultuous period for the regulator that included clashes over vaping, abortion and drug policy, The Wall Street Journal's Liz Essley Whyte reports, citing people familiar with the matter. Makary is seen by other top administration leaders as struggling to manage his agency, sparring frequently with health department officials and at times the White House, the author notes. Biotech stocks that could be impacted by the news include Moderna (MRNA), Sarepta (SRPT), Xencor (XNCR), PTC Therapeutics (PTCT), Biohaven (BHVN), Edgewise Therapeutics (EWTX), Design Therapeutics (DSGN), Ultragenyx (RARE), Avidity Biosciences (RNA), Dyne Therapeutics (DYN), Wave Life Sciences (WVE), MeiraGTx (MGTX), uniQure (QURE), Regenxbio (RGNX), Novavax (NVAX) and Lexeo Therapeutics (LXEO).